THE DEAL, AT A GLANCE
From the announcementAignosis
01What it does” Aignosis' system is designed to provide an initial screening layer for children aged 16 months to nine years.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by Antler, Nikhil Kamath, building, validating the technologyFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedAignosis raised Seed, announced 2026-10-01From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersAignosis raised a ₹4 crore seed round led by Antler and Nikhil Kamath to expand AI-assisted autism and developmental screening across India's healthcare ecosystem.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Aignosis · Financing Record
Explore source-linked visual explanations for Aignosis. Unsupported claims are withheld while source review continues.
Record 13146 · Recorded date: 2026-10-01
Explore company records →